Health News Releases

  • Today June 25
March 29, 11:00
The Medi-Globe Group opens the MGG Campus - a new training and virtual test laboratory
The Medi-Globe Group has opened its own training and virtual test laboratory at its headquarters in Achenmühle, Germany. The Medi-Globe Group Campus (MGG Campus) has state-of-the-art equipment with wh
March 28, 15:00
Publication of definitive end result for Vifor Pharma tender offer
CSL Behring AG, Berne, Switzerland, a wholly-owned subsidiary of global biotechnology leader CSL Limited (ASX: CSL; USOTC: CSLLY), today announced the definitive notice of the end result of its public
March 28, 11:45
Galderma to Highlight Latest Science and Innovation Across Its Product Portfolio at the 2022 AAD Annual Meeting
Galderma, the leading company solely dedicated to advancing the future of dermatology, announced it will be attending the 2022 American Academy of Dermatology Annual Meeting to showcase its latest app
March 28, 10:00
STALICLA Completes Successful Phase 1b Trials for the First Precision Medicine in Autism Spectrum Disorder
STALICLA, a Swiss clinical stage biotech company leading omics-based drug development for patients with neurodevelopmental disorders (NDDs), announced today the highly successful completion of the pha
March 25, 15:40
Tanner Pharma Increases Europe-Based Inventory of Leukine® to Expand Availability and Enhance Response to Potential Radiation Exposure Due to the Ongoing Conflict in Ukraine
Tanner Pharma Group, an international distributor of essential medicines, announced that it has significantly increased its inventory of Leukine (sargramostim, yeast-derived rhuGM-CSF) to be held in E
March 25, 09:40
ViiV Healthcare announces label update for its long-acting HIV treatment, Cabenuva (cabotegravir, rilpivirine), to be initiated with or without an oral lead-in period
For media and investors only ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, today announced
March 23, 16:40
Publication of provisional end result for Vifor Pharma tender offer: Participation rate of 94 percent
Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220322006149/en/ AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR CSL B
March 23, 14:55
Alchemab Selected to Access NVIDIA Cambridge-1 Supercomputer to Advance Machine Learning Enabled Antibody Discovery
Alchemab Therapeutics, a biotechnology company focused on the discovery and development of naturally-occurring protective antibodies and immune repertoire-based patient stratification tools, has been
March 22, 09:02
Dental Prosthetics Sales In Asia Pacific To Top With A Market Valuation of More Than USD 50 Bn by 2030; Owing To The Rising Trends of Cosmetic Dentistry: Fact.MR
According to Fact.MR Latest Analysis, the global dental consumables market is projected to register growth at the rate of nearly 4% over the forecast period of 2020-2030, to reach a market valuation o
No Virus Transmission Detected at 300 Stores With Seoul Viosys UVC Air Purifying Sterilizer
March 21, 10:10
No Virus Transmission Detected at 300 Stores With Seoul Viosys UVC Air Purifying Sterilizer
Seoul Viosys (KOSDAQ: 092190), a global optical semiconductor company, provided free air purifying sterilizers applied with Violeds, its UV LED sterilization solution technology, to more than 300 self
March 17, 16:30
Gelesis® Releases Preliminary National Launch Results for Plenity®: Record-Breaking Levels of Prescriptions and Online Traffic
Gelesis (NYSE: GLS), the maker of Plenity, announced preliminary results from its broad awareness media campaign that debuted January 31, 2022. Within the first three weeks, the company saw a 3-fold i
March 17, 11:35
More Than Half of Physicians Have Been Asked By Patients for an Unapproved COVID-19 Treatment
A new survey from Sermo, a physician-first online community and leader in global HCP insights, found that physicians are facing a challenging onslaught of COVID-19 vaccine and treatment misinformation
March 17, 10:15
Jardiance® (empagliflozin) Phase III EMPA-KIDNEY trial will stop early due to clear positive efficacy in people with chronic kidney disease
The EMPA-KIDNEY trial, evaluating the effect of empagliflozin in adults with chronic kidney disease (CKD), will stop early based on a recommendation from the trial’s Independent Data Monitoring Commit
March 16, 21:05
Aleph Farms Reveals Its Strategy to Replace the Whole Cow as an Alternative to Intensive Cattle Farming
Aleph Farms, the first company to grow cultivated beef steaks, today announced it is expanding its product line to include a unique platform for cell-cultured collagen production. The company’s highly
March 16, 09:07
Smartphone Penetration Is Encouraging The Mindfulness Meditation Apps Usage And Is Expected To Top With A Sales Volume of 180 Mn Latest Study By Fact.MR
As per the analysis conducted by Fact. MR, the global mindfulness meditation apps market is anticipated to procure a market value of USD 180 Mn through 2032. The increasing cases of depression, mood d
March 15, 14:40
Dexcom G7 Receives CE Mark - Next-Generation Continuous Glucose Monitoring System to Revolutionize Diabetes Management
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today it has secured CE Mark (Conformité Européenne) for the Dexcom G7 Cont
March 15, 11:10
Nichi GLOW: Japanese Beta-Glucan, in Children With Autism Spectrum Disorder, Improves Behavior, Sleep, and Gut Microbiome in a Clinical Study
In the first such report, children with Autism spectrum disorder (ASD) showed improvement in behaviour, learning skills and sleep, after oral consumption of AFO-202 strain of black yeast Aureobasidium
March 14, 16:20
Join KOREA PACK & ICPI WEEK 2022 to Be Held June 14 - 17, KINTEX, Korea!
KOREA PACK and ICPI WEEK (Int’l Cosmetic and Pharmaceutical Industry Week), the largest packaging, cosmetic and pharmaceutical exhibition in Korea, will be held at KINTEX from June 14th to 17th as hyb
March 11, 18:04
Blood Cancer Biomarkers Market: Why Is It Expected That The Asian Market Will Outperform Others, Detailed Study By Fact.MR
According to Fact.MR’s Study, the cancer biomarkers market revenue is anticipated to surpass US$ 33 Bn by 2031, representing a 3x increase from 2020. Presently, the market is valued at a little above
March 10, 11:45
Dr. Andreas Amrein Joins Advanced Clinical to Lead Global Development and Expansion in APAC, Europe and Canada
Advanced Clinical, a clinical development and strategic resourcing organization committed to providing a better clinical experience across the drug development journey, is pleased to announce that Dr.
March 10, 09:40
Alvotech Resolves U.S. Patent and Trade Secret Disputes with AbbVie, Securing U.S. Rights for Alvotech’s Proposed High-Concentration Biosimilar (AVT02) for Humira®
Alvotech Holdings S.A. (“Alvotech”), a global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients worldwide, announced today that is has ex
March 09, 09:30
Medical Ventilators Market to exhibit a CAGR of 9.1% during the forecast period 2022-2030: Future Market Insights
Greater emphasis on ramping up the production to address a sudden increase in demand in the time of COVID-19 pandemic is accelerating the growth of the medical ventilators market. The global medical v
March 09, 08:45
ANANDA Scientific and NYU Grossman School of Medicine Announce First Patient Enrolled in the Clinical Trial for Opioid Sparing in Participants with Radiculopathic Pain
ANANDA Scientific Inc., a biotech pharmaceutical company, and NYU Grossman School of Medicine today announced that the first patient has been enrolled in a clinical trial evaluating Nantheia™ A1002N5S
March 08, 17:05
Publication of definitive Interim Result for Vifor Pharma tender offer: CSL Behring AG declares offer successful
Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR CSL Behring AG, Berne, Switzerland, a wholly-owned subsidiary of global biotechnology leader CSL Limited (ASX: CSL; USOTC: CSLLY), tod
March 08, 16:40
Mawi DNA Technologies Nabs CE Certification for Sample Collection Product Portfolio
Mawi DNA Technologies (Mawi), a leader in biosample collection technologies, announces the company received CE Mark and UK MHRA approval for its portfolio of iSWAB non-invasive collection devices. Thi
25 per page50 per page75 per page100 per page